1. Flukiger M. Vorkommen von Trommelschlagel-formigen Fingerend-phalangen ohne chronische Veranderungen an der Lungen oder an Herzen. Wien Med Wochenschr. 1884; 34:1457.
2. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest. 1977; 72:305–309.
3. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest. 1994; 105:1528–1537.
4. Ho V. Current concepts in the management of hepatopulmonary syndrome. Vasc Health Risk Manag. 2008; 4:1035–1041.
5. Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol. 2005; 39:4 Suppl 2. S138–S142.
6. Chang SW, Ohara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis: an animal model of the hepatopulmonary syndrome. Am Rev Respir Dis. 1992; 145(4 Pt 1):798–805.
7. Tieppo J, Vercelino R, Dias AS, Silva Vaz MF, Silveira TR, Marroni CA, et al. Evaluation of the protective effects of quercetin in the hepatopulmonary syndrome. Food Chem Toxicol. 2007; 45:1140–1146.
8. Krowka MJ, Cortese DA. Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. Mayo Clin Proc. 1987; 62:164–173.
9. Singh C, Sager JS. Pulmonary complications of cirrhosis. Med Clin North Am. 2009; 93:871–883.
10. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004; 24:861–880.
11. Lee KN, Yoon SK, Lee JW, Kim KN, Park BH, Kwak JY, et al. Hepatopulmonary syndrome induced by common bile duct ligation in a rabbit model: correlation between pulmonary vascular dilatation on thin-section CT and angiography and serum nitrite concentration or endothelial nitric oxide synthase (eNOS)1 expression. Korean J Radiol. 2004; 5:149–156.
12. Rolla G, Brussino L, Colagrande P, Scappaticci E, Morello M, Bergerone S, et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med. 1998; 129:375–378.
13. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology. 1997; 113:606–614.
14. Zhang HY, Han de W, Su AR, Zhang LT, Zhao ZF, Ji JQ, et al. In testinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors. World J Gastroenterol. 2007; 13:6385–6395.
15. Zhang HY, Han DW, Wang XG, Zhao YC, Zhou X, Zhao HZ. Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome. World J Gastroenterol. 2005; 11:567–572.
16. Sztrymf B, Rabiller A, Nunes H, Savale L, Lebrec D, Le Pape A, et al. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J. 2004; 23:752–758.
17. Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology. 1998; 27:1265–1274.
18. Santus R, Perdrix L, Haigle J, Morliere P, Maziere JC, Maziere C, et al. Daflon as a cellular antioxidant and a membrane-stabilizing agent in human fibroblasts irradiated by ultraviolet A radiation. Photodermatol Photoimmunol Photomed. 1991; 8:200–205.
19. Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol. 1988; 37:837–841.